EHRA Premium Access

No more therapy delivery after ventricular tachycardia ablation? Will my patient fear shock again?

Congress Session

About the speaker

Doctor Antonio Berruezo Sanchez

Teknon Medical Center, Barcelona (Spain)
14 presentations
0 follower

4 more presentations in this session

Primary prevention in systolic dysfunction/heart failure patients: use, misuse, and underuse

Speaker: Associate Professor M. Zabel (Gottingen, DE)

Thumbnail

Antitachycardia pacing and VT termination: fact or fancy? What is the impact on shock reduction from a patient's perspective?

Speaker: Doctor U. Birgersdotter-Green (San Diego, US)

Thumbnail

Noninvasive risk factors for the prediction of inducibility on programmed ventricular stimulation in post-MI patients with ejection fraction over 40% at SCD risk, insights from the PRESERVE EF study

Speaker: Doctor K. Trachanas (Athens, GR)

Thumbnail

Sudden death prevention and ICD therapy: unsolved issues - discussion

Thumbnail

Access the full session

Sudden death prevention and ICD therapy: unsolved issues

Speakers: Doctor A. Berruezo Sanchez, Associate Professor M. Zabel, Doctor U. Birgersdotter-Green, Doctor K. Trachanas
Thumbnail

About the event

Image

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

This platform is supported by

logo Novo Nordisk